(Q45374016)

English

Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus-transgenic mice by peroxisome proliferator-activated receptor gamma-independent regulation of nucleophosmin

scientific article published in August 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus-transgenic mice by peroxisome proliferator-activated receptor gamma-independent regulation of nucleophosmin (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Guido Mastrobuoni

11

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Elisabetta Ceni

object named as

Elisabetta Ceni

2

0 references

Giuseppe Pieraccini

object named as

Giuseppe Pieraccini

13

0 references

object named as

Mirko Tarocchi

5

0 references

object named as

Stefano Milani

15

0 references

author name string

Francesca Buccoliero

6

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Francesca Lisi

7

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Laura Cioni

8

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Barbara Ottanelli

9

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Valeria Foresta

10

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Gloriano Moneti

12

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Calogero Surrenti

14

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

language of work or name

0 references

publication date

1 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

493-505

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Estimating the world cancer burden: Globocan 2000.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

Design and endpoints of clinical trials in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

Thiazolidinediones: effects on insulin resistance and the cardiovascular system

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

Peroxisome proliferator-activated receptor-gamma: a versatile metabolic regulator

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

The potential of antidiabetic thiazolidinediones for anticancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

Peroxisome proliferator-activated receptor gamma pathway targeting in carcinogenesis: implications for chemoprevention

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

Activators of the nuclear receptor PPARgamma enhance colon polyp formation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

PPAR gamma signaling exacerbates mammary gland tumor development

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

Peroxisome proliferator-activated receptor gamma-mediated transcriptional up-regulation of the hepatocyte growth factor gene promoter via a novel composite cis-acting element

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

Peroxisome proliferator-activated receptor gamma inhibition prevents adhesion to the extracellular matrix and induces anoikis in hepatocellular carcinoma cells.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

Identification and characterization of peroxisome proliferator response element in the mouse GLUT2 promoter

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

Separate origins of hepatitis B virus surface antigen-negative foci and hepatocellular carcinomas in transgenic HBsAg (alb/psx) mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

Nucleophosmin and cancer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

Thr199 phosphorylation targets nucleophosmin to nuclear speckles and represses pre-mRNA processing

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

Thiazolidinediones inhibit insulin-like growth factor-i-induced activation of p70S6 kinase and suppress insulin-like growth factor-I tumor-promoting activity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

Hypoxia-induced nucleophosmin protects cell death through inhibition of p53.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

Fat and beyond: the diverse biology of PPARgamma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

Antidiabetic thiazolidinediones induce ductal differentiation but not apoptosis in pancreatic cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

Thiazolidinediones: a new class of antidiabetic drugs

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

Genetic deficiency in Pparg does not alter development of experimental prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

Loss of the peroxisome proliferation-activated receptor gamma (PPARgamma ) does not affect mammary development and propensity for tumor formation but leads to reduced fertility

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

Peroxisome proliferator-activated receptor gamma is highly expressed in pancreatic cancer and is associated with shorter overall survival times.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

Enhanced expression of peroxisome proliferator-activated receptor gamma in epithelial ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

High-level expression of RXRalpha and the presence of endogenous ligands contribute to expression of a peroxisome proliferator-activated receptor-responsive gene in hepatoma cells.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocation.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

PPARgamma-independent antitumor effects of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

A novel mechanism by which thiazolidinediones facilitate the proteasomal degradation of cyclin D1 in cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

Increased expression of nucleophosmin/B23 in hepatocellular carcinoma and correlation with clinicopathological parameters.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

AMP-activated protein kinase and cancer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

AMP-activated protein kinase induces a p53-dependent metabolic checkpoint

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

Resistance to UV-induced cell-killing in nucleophosmin/B23 over-expressed NIH 3T3 fibroblasts: enhancement of DNA repair and up-regulation of PCNA in association with nucleophosmin/B23 over-expression

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

Negative regulation of p53 by nucleophosmin antagonizes stress-induced apoptosis in human normal and malignant hematopoietic cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

Nucleophosmin interacts with and inhibits the catalytic function of eukaryotic initiation factor 2 kinase PKR

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

21 January 2018

Carboxyfluorescein (CFSE) labelling of hepatocytes for short-term localization following intraportal transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

7 January 2021

based on heuristic

inferred from DOI database lookup

Acetaldehyde Inhibits PPARγ via H2O2-Mediated c-Abl Activation in Human Hepatic Stellate Cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23669

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.23669

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45374016&oldid=2075957878"